Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Dec;85(12):1958–1963. doi: 10.1054/bjoc.2001.2178

E-cadherin as a prognostic indicator in primary breast cancer

C Parker 1, R S Rampaul 2, S E Pinder 1, J A Bell 1, P M Wencyk 1, R W Blamey 2, R I Nicholson 3, J F R Robertson 2
PMCID: PMC2364028  PMID: 11747340

Abstract

Epithelial cadherin (E-CD) is a member of the cadherin family of cell adhesion molecules and has been implicated as an invasion suppressor molecule in vitro and in vivo. We analysed 174 breast tumours from the Nottingham/Tenovus Breast Cancer Series immunohistochemically for E-CD expression using the mouse monoclonal antibody HECD-1 (Zymed Laboratories Inc.). In normal epithelial cells E-CD was strongly expressed at cell–cell boundaries. 66% of the breast cancers examined had reduced intensity of E-CD expression with 74% having significant reductions in the proportion of E-CD-positive tumour cells. Using a combined intensity/proportion score, significant associations were found between E-CD expression and tumour type (P ≤ 0.001). ER status (P = 0.026) and histological grade (P = 0.031). Expression of E-CD was not found to be related to recurrence, distant metastases, lymph node stage, vascular invasion, primary tumour size, prognostic group or survival. Thus E-CD expression in human breast cancer appears to have minimal prognostic value, but may have a role as a phenotypic marker. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: Breast cancer, immunohistochemistry, cadherin, prognosis

Full Text

The Full Text of this article is available as a PDF (91.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becker K. F., Reich U., Schott C., Becker I., Berx G., van Roy F., Höfler H. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online. Hum Mutat. 1999;13(2):171–171. doi: 10.1002/(SICI)1098-1004(1999)13:2<171::AID-HUMU14>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  2. Behrens J. The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res Treat. 1993;24(3):175–184. doi: 10.1007/BF01833258. [DOI] [PubMed] [Google Scholar]
  3. Berx G., Cleton-Jansen A. M., Strumane K., de Leeuw W. J., Nollet F., van Roy F., Cornelisse C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. 1996 Nov 7;13(9):1919–1925. [PubMed] [Google Scholar]
  4. Birchmeier W., Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994 May 27;1198(1):11–26. doi: 10.1016/0304-419x(94)90003-5. [DOI] [PubMed] [Google Scholar]
  5. Bracke M. E., Charlier C., Bruyneel E. A., Labit C., Mareel M. M., Castronovo V. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res. 1994 Sep 1;54(17):4607–4609. [PubMed] [Google Scholar]
  6. Bussemakers M. J., Giroldi L. A., van Bokhoven A., Schalken J. A. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter. Biochem Biophys Res Commun. 1994 Sep 15;203(2):1284–1290. doi: 10.1006/bbrc.1994.2321. [DOI] [PubMed] [Google Scholar]
  7. Charpin C., Garcia S., Bouvier C., Devictor B., Andrac L., Choux R., Lavaut M. E-cadherin quantitative immunocytochemical assays in breast carcinomas. J Pathol. 1997 Mar;181(3):294–300. doi: 10.1002/(SICI)1096-9896(199703)181:3<294::AID-PATH772>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  8. Dorudi S., Sheffield J. P., Poulsom R., Northover J. M., Hart I. R. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol. 1993 Apr;142(4):981–986. [PMC free article] [PubMed] [Google Scholar]
  9. Ellis I. O., Galea M., Broughton N., Locker A., Blamey R. W., Elston C. W. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology. 1992 Jun;20(6):479–489. doi: 10.1111/j.1365-2559.1992.tb01032.x. [DOI] [PubMed] [Google Scholar]
  10. Elston C. W., Ellis I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991 Nov;19(5):403–410. doi: 10.1111/j.1365-2559.1991.tb00229.x. [DOI] [PubMed] [Google Scholar]
  11. Gamallo C., Palacios J., Suarez A., Pizarro A., Navarro P., Quintanilla M., Cano A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol. 1993 Apr;142(4):987–993. [PMC free article] [PubMed] [Google Scholar]
  12. Gonzalez M. A., Pinder S. E., Wencyk P. M., Bell J. A., Elston C. W., Nicholson R. I., Robertson J. F., Blamey R. W., Ellis I. O. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. J Pathol. 1999 Apr;187(5):523–529. doi: 10.1002/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  13. Gupta S. K., Douglas-Jones A. G., Jasani B., Morgan J. M., Pignatelli M., Mansel R. E. E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast. Virchows Arch. 1997 Jan;430(1):23–28. doi: 10.1007/BF01008012. [DOI] [PubMed] [Google Scholar]
  14. Hashizume R., Koizumi H., Ihara A., Ohta T., Uchikoshi T. Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Histopathology. 1996 Aug;29(2):139–146. doi: 10.1046/j.1365-2559.1996.d01-499.x. [DOI] [PubMed] [Google Scholar]
  15. Hiraguri S., Godfrey T., Nakamura H., Graff J., Collins C., Shayesteh L., Doggett N., Johnson K., Wheelock M., Herman J. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res. 1998 May 1;58(9):1972–1977. [PubMed] [Google Scholar]
  16. Hunt N. C., Douglas-Jones A. G., Jasani B., Morgan J. M., Pignatelli M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch. 1997 Apr;430(4):285–289. doi: 10.1007/BF01092751. [DOI] [PubMed] [Google Scholar]
  17. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 1993 Sep;9(9):317–321. doi: 10.1016/0168-9525(93)90250-l. [DOI] [PubMed] [Google Scholar]
  18. Lipponen P., Saarelainen E., Ji H., Aaltomaa S., Syrjänen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol. 1994 Oct;174(2):101–109. doi: 10.1002/path.1711740206. [DOI] [PubMed] [Google Scholar]
  19. Maguire T. M., Shering S. G., McDermott E. W., O'Higgins N., Fennelly J. J., Crown J., Duffy M. J. Assay of E-cadherin by ELISA in human breast cancers. Eur J Cancer. 1997 Mar;33(3):404–408. doi: 10.1016/s0959-8049(97)89013-2. [DOI] [PubMed] [Google Scholar]
  20. Mareel M. M., Behrens J., Birchmeier W., De Bruyne G. K., Vleminckx K., Hoogewijs A., Fiers W. C., Van Roy F. M. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer. 1991 Apr 1;47(6):922–928. doi: 10.1002/ijc.2910470623. [DOI] [PubMed] [Google Scholar]
  21. Mayer B., Johnson J. P., Leitl F., Jauch K. W., Heiss M. M., Schildberg F. W., Birchmeier W., Funke I. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res. 1993 Apr 1;53(7):1690–1695. [PubMed] [Google Scholar]
  22. Meiners S., Brinkmann V., Naundorf H., Birchmeier W. Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene. 1998 Jan 8;16(1):9–20. doi: 10.1038/sj.onc.1201486. [DOI] [PubMed] [Google Scholar]
  23. Moll R., Mitze M., Frixen U. H., Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol. 1993 Dec;143(6):1731–1742. [PMC free article] [PubMed] [Google Scholar]
  24. Oka H., Shiozaki H., Kobayashi K., Inoue M., Tahara H., Kobayashi T., Takatsuka Y., Matsuyoshi N., Hirano S., Takeichi M. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 1993 Apr 1;53(7):1696–1701. [PubMed] [Google Scholar]
  25. Perl A. K., Wilgenbus P., Dahl U., Semb H., Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998 Mar 12;392(6672):190–193. doi: 10.1038/32433. [DOI] [PubMed] [Google Scholar]
  26. Pinder S. E., Ellis I. O., Galea M., O'Rouke S., Blamey R. W., Elston C. W. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology. 1994 Jan;24(1):41–47. doi: 10.1111/j.1365-2559.1994.tb01269.x. [DOI] [PubMed] [Google Scholar]
  27. Pizarro A., Benito N., Navarro P., Palacios J., Cano A., Quintanilla M., Contreras F., Gamallo C. E-cadherin expression in basal cell carcinoma. Br J Cancer. 1994 Jan;69(1):157–162. doi: 10.1038/bjc.1994.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rasbridge S. A., Gillett C. E., Sampson S. A., Walsh F. S., Millis R. R. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol. 1993 Feb;169(2):245–250. doi: 10.1002/path.1711690211. [DOI] [PubMed] [Google Scholar]
  29. Rimm D. L., Sinard J. H., Morrow J. S. Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab Invest. 1995 May;72(5):506–512. [PubMed] [Google Scholar]
  30. Schipper J. H., Frixen U. H., Behrens J., Unger A., Jahnke K., Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991 Dec 1;51(23 Pt 1):6328–6337. [PubMed] [Google Scholar]
  31. Shimoyama Y., Nagafuchi A., Fujita S., Gotoh M., Takeichi M., Tsukita S., Hirohashi S. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res. 1992 Oct 15;52(20):5770–5774. [PubMed] [Google Scholar]
  32. Siitonen S. M., Kononen J. T., Helin H. J., Rantala I. S., Holli K. A., Isola J. J. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol. 1996 Apr;105(4):394–402. doi: 10.1093/ajcp/105.4.394. [DOI] [PubMed] [Google Scholar]
  33. van der Wurff A. A., ten Kate J., van der Linden E. P., Dinjens W. N., Arends J. W., Bosman F. T. L-CAM expression in normal, premalignant, and malignant colon mucosa. J Pathol. 1992 Nov;168(3):287–291. doi: 10.1002/path.1711680308. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES